The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples